Generation of recombinant factor H proteins to control alternative pathway activation in the kidney
The alternative pathway (AP) of complement activation is implicated in several renal pathologies. These include membranoproliferative glomerulonephritis (MPGN) type II and atypical haemolytic uraemic syndrome (aHUS). Factor H (FH), comprised of 20 short consensus repeats (SCRs), is the primary regul...
Main Author: | Hunze, Eva-Maria |
---|---|
Published: |
University of Newcastle upon Tyne
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.594505 |
Similar Items
-
Anaemia in kidney transplant recipients : effects of recombinant human erythropoietin and the potential role of mycophenolate mofetil
by: Pile, Taryn
Published: (2012) -
Physical activity, kidney function and kidney injury
by: Junglee, Naushad Ali
Published: (2015) -
The production and use of transgenic mouse models to study the role of complement pathway activation in progressive kidney disease
by: AlGhadban, Samy Taha Abdo
Published: (2017) -
Generation of mouse models for uromodulin-associated kidney diseases : Renal function defect and tubulointerstitial damage upon expression of transgenic mutant protein
by: Bernascone, Ilenia
Published: (2010) -
Can the inhibition of TAFI affect kidney plasmin activity, ECM accumulation and the progression of experimental chronic kidney disease?
by: Atkinson, John
Published: (2013)